3Hassan M, Ljungman P, Ringden O, et al. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxity[J]. Bone Marrow Transplant, 2000, 25 (3) : 915.
4Seber A , Shu X, Defor T, et al. Risk factors for severe hemorrhagic cystitis following BMT[J]. Bone Marrow Transplant, 1999, 23 (2) : 35.
5Milena MV,Francisco YB,Macêdo,et al.Ternatin,a flavonoid,prevents cyclophosphamide and ifosfamideinduced hemorrhagic cystitis in rats[J].Phytother Res,2004,18(2):135-141.
6Wolf-Dietrich B,Tobias E,Roman B,et al.Angiogenesis inhibition by angiostatin,endostatin and TNP-470 prevents cyclophosphamide induced cystitis[J].Angiogenesis,2004,7(1):69-73.
7Kanat O,Kurt E,Yalcinkaya U,et al.comparison of uroprotective efficacy of mesna and amifostine in cyclophosphamide induced hemorrhagic cystitis in rats[J].Indian J Cancer,2006,43(1):12-15.
8Satoshi T,Nobuo S,Mikio Y,et al.Inactivation of acrolein by sodium 2-mercaptoethanesulfonate using headspace-solid-phase microextraction gas chromatography and mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci,2003,791(1-2):365-369.
9Satoshi T,Nobuo S,Akira N,et al.Monitoring of urinary acrolein concentration in patients receiving cyclophosphamide and ifosphamide[J].J Chromatogr B Analyt Technol Biomed Life Sci,2004,806(1):59-63.
10Laszlo D,Bosi A,Guidi S,et al.Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation[J].Haematologica,1995,80(5):421-425.